S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Nearing 50 Supreme Court arguments in, lawyer Lisa Blatt keeps winning
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Nearing 50 Supreme Court arguments in, lawyer Lisa Blatt keeps winning
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Nearing 50 Supreme Court arguments in, lawyer Lisa Blatt keeps winning
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Nearing 50 Supreme Court arguments in, lawyer Lisa Blatt keeps winning
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
NASDAQ:NYXH

Nyxoah (NYXH) Stock Price, News & Analysis

$9.01
-0.71 (-7.30%)
(As of 04/12/2024 ET)
Today's Range
$8.60
$10.25
50-Day Range
$9.01
$19.50
52-Week Range
$4.00
$20.00
Volume
35,483 shs
Average Volume
46,002 shs
Market Capitalization
$224.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.60

Nyxoah MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
128.6% Upside
$20.60 Price Target
Short Interest
Healthy
2.78% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.49mentions of Nyxoah in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.88 out of 5 stars

NYXH stock logo

About Nyxoah Stock (NASDAQ:NYXH)

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

NYXH Stock Price History

NYXH Stock News Headlines

Nyxoah Appoints Maurits Boon As Chief Medical Officer
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Nyxoah S.A. (NYXH) Q4 2023 Earnings Call Transcript
Preview: Nyxoah's Earnings
Nyxoah SA Ordinary Shares NYXH
Nyxoah Announces 2024 Strategic Priorities
See More Headlines
Receive NYXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nyxoah and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
4/13/2024
Next Earnings (Estimated)
5/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:NYXH
Employees
137
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.60
High Stock Price Target
$27.00
Low Stock Price Target
$14.00
Potential Upside/Downside
+128.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

Net Income
$-46,770,000.00
Net Margins
-993.28%
Pretax Margin
-1,027.03%

Debt

Sales & Book Value

Annual Sales
$4.35 million
Book Value
$5.08 per share

Miscellaneous

Free Float
N/A
Market Cap
$224.71 million
Optionable
Not Optionable
Beta
1.50
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Robert Taub MBA (Age 77)
    Co-Founder & Chairman
    Comp: $138.25k
  • Mr. Olivier Taelman (Age 52)
    CEO & Executive Director
    Comp: $683.69k
  • Mr. Loic Moreau (Age 43)
    Chief Financial Officer
    Comp: $343.41k
  • Mr. Bruno Onkelinx
    Chief Technology Officer
  • Mikaela Kirkwood
    Corporate Communication & Investor Relations Manager
  • Ms. An Moonen
    General Counsel
  • Mr. Remi Renard
    Vice President of Market & Market Access
  • Ms. Inge Vanwittenbergh
    Global Human Resource Director
  • Mr. David M. DeMartino
    Chief Strategy Officer
  • Mr. Jeyakumar Subbaroyan
    Chief Clinical Officer

NYXH Stock Analysis - Frequently Asked Questions

Should I buy or sell Nyxoah stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nyxoah in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" NYXH shares.
View NYXH analyst ratings
or view top-rated stocks.

What is Nyxoah's stock price target for 2024?

6 analysts have issued 1 year target prices for Nyxoah's shares. Their NYXH share price targets range from $14.00 to $27.00. On average, they predict the company's stock price to reach $20.60 in the next twelve months. This suggests a possible upside of 128.6% from the stock's current price.
View analysts price targets for NYXH
or view top-rated stocks among Wall Street analysts.

How have NYXH shares performed in 2024?

Nyxoah's stock was trading at $4.64 on January 1st, 2024. Since then, NYXH shares have increased by 94.2% and is now trading at $9.01.
View the best growth stocks for 2024 here
.

When is Nyxoah's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 21st 2024.
View our NYXH earnings forecast
.

How were Nyxoah's earnings last quarter?

Nyxoah S.A. (NASDAQ:NYXH) announced its quarterly earnings results on Tuesday, March, 5th. The company reported ($0.41) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.41). The company had revenue of $1.96 million for the quarter, compared to the consensus estimate of $2.01 million. Nyxoah had a negative trailing twelve-month return on equity of 38.58% and a negative net margin of 993.28%.

When did Nyxoah IPO?

Nyxoah (NYXH) raised $83 million in an initial public offering (IPO) on Friday, July 2nd 2021. The company issued 2,760,000 shares at $30.00 per share.

How do I buy shares of Nyxoah?

Shares of NYXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NYXH) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners